Display options
Cite
Kaminski CA, Angueira E. Chlorpropamide-induced cholestatic liver failure resulting in death. Endocr Pract. 1996;2(3):191-2doi: 10.4158/EP.2.3.191.
Kaminski, C. A., & Angueira, E. (1996). Chlorpropamide-induced cholestatic liver failure resulting in death. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2(3), 191-2. https://doi.org/10.4158/EP.2.3.191
Kaminski, C A, and Angueira, E. "Chlorpropamide-induced cholestatic liver failure resulting in death." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 2,3 (1996): 191-2. doi: https://doi.org/10.4158/EP.2.3.191
Kaminski CA, Angueira E. Chlorpropamide-induced cholestatic liver failure resulting in death. Endocr Pract. 1996 May-Jun;2(3):191-2. doi: 10.4158/EP.2.3.191. PMID: 15251538.
Copy Download .nbib Format: NLM
Share it on

Endocr Pract. 1996 May-Jun;2(3):191-2. doi: 10.4158/EP.2.3.191.

Chlorpropamide-induced cholestatic liver failure resulting in death.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

C A Kaminski, E Angueira

Affiliations

  1. Department of Pharmacy Practice, Nova Southeastern University, Miami Beach, Florida 33162, USA.

PMID: 15251538 DOI: 10.4158/EP.2.3.191

Abstract

OBJECTIVE: To describe the first reported case of a death that occurred as a result of chlorpropamide-induced cholestatic liver disease.

METHODS: We review the clinical and laboratory details of an 81-year-old man with type II diabetes mellitus, who was hospitalized because of nausea, vomiting, and jaundice.

RESULTS: The patient had been taking a sulfonylurea (chlorpropamide, 250 mg orally three times a day) for 2 months. On initial assessment, the patient was noted to have cutaneous and scleral icterus and an erythematous maculopapular rash on the torso. The alkaline phosphatase level was substantially increased, and the transaminases were mildly increased. Use of all medications was discontinued. In the hospital, the patient's status rapidly deteriorated, and death ensued after cardiopulmonary arrest on day 6.

CONCLUSION: The findings were consistent with a hypersensitivity reaction to chlorpropamide that ultimately resulted in fulminant cholestatic liver disease and death.

Publication Types